Edition:
India

Bellicum Pharmaceuticals Inc (BLCM.OQ)

BLCM.OQ on NASDAQ Stock Exchange Global Market

2.93USD
17 May 2019
Change (% chg)

$-0.14 (-4.56%)
Prev Close
$3.07
Open
$3.01
Day's High
$3.08
Day's Low
$2.90
Volume
74,133
Avg. Vol
79,714
52-wk High
$10.23
52-wk Low
$2.74

About

Bellicum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing cellular immunotherapies for various forms of cancer, including hematological cancers and solid tumors, as well as orphan inherited blood disorders. The Company uses its chemical induction of... (more)

Overall

Beta: --
Market Cap(Mil.): $377.79
Shares Outstanding(Mil.): 33.23
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates